{"id":"https://openalex.org/W4200375150","doi":"https://doi.org/10.1021/acsinfecdis.1c00444","title":"Transferring Microclusters of P. aeruginosa Biofilms to the Air\u2013Liquid Interface of Bronchial Epithelial Cells for Repeated Deposition of Aerosolized Tobramycin","display_name":"Transferring Microclusters of P. aeruginosa Biofilms to the Air\u2013Liquid Interface of Bronchial Epithelial Cells for Repeated Deposition of Aerosolized Tobramycin","publication_year":2021,"publication_date":"2021-12-17","ids":{"openalex":"https://openalex.org/W4200375150","doi":"https://doi.org/10.1021/acsinfecdis.1c00444","pmid":"https://pubmed.ncbi.nlm.nih.gov/34919390"},"language":"en","primary_location":{"id":"doi:10.1021/acsinfecdis.1c00444","doi":"https://doi.org/10.1021/acsinfecdis.1c00444","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsinfecdis.1c00444","pdf_url":null,"source":{"id":"https://openalex.org/S2764646616","display_name":"ACS Infectious Diseases","issn_l":"2373-8227","issn":["2373-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200375150"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.22028/d291-37165","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048008366","display_name":"Justus Constantin Horstmann","orcid":"https://orcid.org/0000-0002-0341-3631","observed_orcids":["https://orcid.org/0000-0002-0341-3631"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]},{"id":"https://openalex.org/I91712215","display_name":"Saarland University","ror":"https://ror.org/01jdpyv68","country_code":"DE","type":"education","lineage":["https://openalex.org/I91712215"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Justus C. Horstmann","raw_affiliation_strings":["Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","Department of Pharmacy, Saarland University, 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]},{"raw_affiliation_string":"Department of Pharmacy, Saarland University, 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I91712215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034674411","display_name":"Annabelle Laric","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91712215","display_name":"Saarland University","ror":"https://ror.org/01jdpyv68","country_code":"DE","type":"education","lineage":["https://openalex.org/I91712215"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Annabelle Laric","raw_affiliation_strings":["Center for Molecular Signaling, Saarland University, Kirrbergerstr./Geb. 46, 66421 Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Signaling, Saarland University, Kirrbergerstr./Geb. 46, 66421 Homburg, Germany","institution_ids":["https://openalex.org/I91712215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023161770","display_name":"Annette S. Boese","orcid":"https://orcid.org/0000-0002-5166-7425","observed_orcids":["https://orcid.org/0000-0002-5166-7425"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Annette Boese","raw_affiliation_strings":["Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069969867","display_name":"Daniela Yildiz","orcid":"https://orcid.org/0000-0002-9702-8581","observed_orcids":["https://orcid.org/0000-0002-9702-8581"]},"institutions":[{"id":"https://openalex.org/I91712215","display_name":"Saarland University","ror":"https://ror.org/01jdpyv68","country_code":"DE","type":"education","lineage":["https://openalex.org/I91712215"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Daniela Yildiz","raw_affiliation_strings":["Center for Molecular Signaling, Saarland University, Kirrbergerstr./Geb. 46, 66421 Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Signaling, Saarland University, Kirrbergerstr./Geb. 46, 66421 Homburg, Germany","institution_ids":["https://openalex.org/I91712215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010202847","display_name":"Teresa R\u00f6hrig","orcid":"https://orcid.org/0000-0001-6468-2950","observed_orcids":["https://orcid.org/0000-0001-6468-2950"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Teresa R\u00f6hrig","raw_affiliation_strings":["Department of Drug Design and Optimization (DDOP), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Optimization (DDOP), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054315057","display_name":"Martin Empting","orcid":"https://orcid.org/0000-0002-0503-5830","observed_orcids":["https://orcid.org/0000-0002-0503-5830"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Empting","raw_affiliation_strings":["Department of Drug Design and Optimization (DDOP), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Design and Optimization (DDOP), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089925736","display_name":"Nicolas A. Frank","orcid":"https://orcid.org/0000-0001-7170-2366","observed_orcids":["https://orcid.org/0000-0001-7170-2366"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicolas Frank","raw_affiliation_strings":["Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052960915","display_name":"Daniel Krug","orcid":"https://orcid.org/0000-0002-3664-1884","observed_orcids":["https://orcid.org/0000-0002-3664-1884"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Daniel Krug","raw_affiliation_strings":["Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077818118","display_name":"Rolf M\u00fcller","orcid":"https://orcid.org/0000-0002-1042-5665","observed_orcids":["https://orcid.org/0000-0002-1042-5665","https://orcid.org/0000-0001-6571-6630"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rolf M\u00fcller","raw_affiliation_strings":["Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030743334","display_name":"Nicole Schneider\u2010Daum","orcid":"https://orcid.org/0000-0001-9319-2010","observed_orcids":["https://orcid.org/0000-0001-9319-2010"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicole Schneider-Daum","raw_affiliation_strings":["Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070307598","display_name":"Cristiane de Souza Carvalho\u2010Wodarz","orcid":"https://orcid.org/0000-0002-2560-675X","observed_orcids":["https://orcid.org/0000-0002-2560-675X"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Cristiane de Souza Carvalho-Wodarz","raw_affiliation_strings":["Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany"],"raw_orcid":"https://orcid.org/0000-0002-2560-675X","affiliations":[{"raw_affiliation_string":"Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001597366","display_name":"Claus\u2010Michael Lehr","orcid":"https://orcid.org/0000-0002-5864-8462","observed_orcids":["https://orcid.org/0000-0002-5864-8462"]},"institutions":[{"id":"https://openalex.org/I4210142777","display_name":"Helmholtz Institute for Pharmaceutical Research Saarland","ror":"https://ror.org/042dsac10","country_code":"DE","type":"government","lineage":["https://openalex.org/I1305996414","https://openalex.org/I4210124929","https://openalex.org/I4210142777"]},{"id":"https://openalex.org/I91712215","display_name":"Saarland University","ror":"https://ror.org/01jdpyv68","country_code":"DE","type":"education","lineage":["https://openalex.org/I91712215"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Claus-Michael Lehr","raw_affiliation_strings":["Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","Department of Pharmacy, Saarland University, 66123 Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I4210142777"]},{"raw_affiliation_string":"Department of Pharmacy, Saarland University, 66123 Saarbr\u00fccken, Germany","institution_ids":["https://openalex.org/I91712215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001597366","https://openalex.org/A5070307598"],"corresponding_institution_ids":["https://openalex.org/I4210142777","https://openalex.org/I91712215"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.653,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.59809453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"8","issue":"1","first_page":"137","last_page":"149"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10593","display_name":"Bacterial biofilms and quorum sensing","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10593","display_name":"Bacterial biofilms and quorum sensing","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9010000228881836},{"id":"https://openalex.org/keywords/air-liquid-interface","display_name":"air-liquid interface","score":0.8939999938011169},{"id":"https://openalex.org/keywords/bronchial-epithelial-cells","display_name":"bronchial epithelial cells","score":0.9010000228881836},{"id":"https://openalex.org/keywords/epithelial-barrier-function","display_name":"epithelial barrier function","score":0.6959999799728394},{"id":"https://openalex.org/keywords/quorum-sensing","display_name":"quorum sensing","score":0.8889999985694885},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cell-cell-adhesion","display_name":"cell-cell adhesion","score":0.7170000076293945},{"id":"https://openalex.org/keywords/host-cell-viability","display_name":"host cell viability","score":0.5239999890327454},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.9300000071525574},{"id":"https://openalex.org/keywords/anti-infective-drug-development","display_name":"anti-infective drug development","score":0.75}],"concepts":[{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.6615191698074341},{"id":"https://openalex.org/C118687296","wikidata":"https://www.wikidata.org/wiki/Q905754","display_name":"Quorum sensing","level":4,"score":0.6523658037185669},{"id":"https://openalex.org/C58123911","wikidata":"https://www.wikidata.org/wiki/Q467410","display_name":"Biofilm","level":3,"score":0.6417149305343628},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6285020112991333},{"id":"https://openalex.org/C2778974779","wikidata":"https://www.wikidata.org/wiki/Q1758380","display_name":"Tobramycin","level":4,"score":0.6189853549003601},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5467180609703064},{"id":"https://openalex.org/C51911345","wikidata":"https://www.wikidata.org/wiki/Q4863604","display_name":"Barrier function","level":2,"score":0.47427162528038025},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4596230089664459},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4240497648715973},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.41669604182243347},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4150822162628174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38224661350250244},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.2625359892845154},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09909677505493164},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014031","descriptor_name":"Tobramycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018441","descriptor_name":"Biofilms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acsinfecdis.1c00444","doi":"https://doi.org/10.1021/acsinfecdis.1c00444","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsinfecdis.1c00444","pdf_url":null,"source":{"id":"https://openalex.org/S2764646616","display_name":"ACS Infectious Diseases","issn_l":"2373-8227","issn":["2373-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:34919390","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34919390","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS infectious diseases","raw_type":"Journal Article"},{"id":"doi:10.22028/d291-37165","doi":"https://doi.org/10.22028/d291-37165","is_oa":true,"landing_page_url":"https://doi.org/10.22028/d291-37165","pdf_url":null,"source":{"id":"https://openalex.org/S4377196499","display_name":"Publications of the UdS (Saarland University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I91712215","host_organization_name":"Saarland University","host_organization_lineage":["https://openalex.org/I91712215"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Collection"}],"best_oa_location":{"id":"doi:10.22028/d291-37165","doi":"https://doi.org/10.22028/d291-37165","is_oa":true,"landing_page_url":"https://doi.org/10.22028/d291-37165","pdf_url":null,"source":{"id":"https://openalex.org/S4377196499","display_name":"Publications of the UdS (Saarland University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I91712215","host_organization_name":"Saarland University","host_organization_lineage":["https://openalex.org/I91712215"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Collection"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W17631051","https://openalex.org/W1562607772","https://openalex.org/W1834210733","https://openalex.org/W1974939755","https://openalex.org/W1975572445","https://openalex.org/W1992499848","https://openalex.org/W2009119435","https://openalex.org/W2045825103","https://openalex.org/W2065386792","https://openalex.org/W2078988411","https://openalex.org/W2097351928","https://openalex.org/W2102072203","https://openalex.org/W2108871276","https://openalex.org/W2136338434","https://openalex.org/W2146054291","https://openalex.org/W2149908911","https://openalex.org/W2153670876","https://openalex.org/W2168504646","https://openalex.org/W2168879981","https://openalex.org/W2293665796","https://openalex.org/W2298066656","https://openalex.org/W2407944729","https://openalex.org/W2560723352","https://openalex.org/W2597317169","https://openalex.org/W2603755876","https://openalex.org/W2614795171","https://openalex.org/W2793568682","https://openalex.org/W2890472136","https://openalex.org/W2907565641","https://openalex.org/W2914129368","https://openalex.org/W2947765278","https://openalex.org/W2971410519","https://openalex.org/W2979382042","https://openalex.org/W2984521888","https://openalex.org/W2990785561","https://openalex.org/W3007527647","https://openalex.org/W3014633359","https://openalex.org/W3036742745","https://openalex.org/W3044054438","https://openalex.org/W3080133859","https://openalex.org/W3084906501","https://openalex.org/W3106721353","https://openalex.org/W3139139445","https://openalex.org/W3153435707","https://openalex.org/W3161830322","https://openalex.org/W3164491831"],"related_works":["https://openalex.org/W3036742745","https://openalex.org/W2146054291","https://openalex.org/W1992393617","https://openalex.org/W4286855061","https://openalex.org/W4407701803","https://openalex.org/W3168374098","https://openalex.org/W2080212245","https://openalex.org/W2130663948","https://openalex.org/W2597408442","https://openalex.org/W2781412151"],"abstract_inverted_index":{"As":[0],"an":[1],"alternative":[2],"to":[3,150,157,163,197],"technically":[4],"demanding":[5],"and":[6,15,26,44,58,87,106,128,140,177,190,228],"ethically":[7],"debatable":[8],"animal":[9],"models,":[10],"the":[11,23,30,36,100,174,184,198,203,219,222],"use":[12],"of":[13,32,92,134,207,225],"organotypic":[14],"disease-relevant":[16],"human":[17,79],"cell":[18,42,67,82,117,123,159],"culture":[19,68],"models":[20],"may":[21],"improve":[22],"throughput,":[24],"speed,":[25],"success":[27],"rate":[28],"for":[29,76,161,221,232],"translation":[31],"novel":[33,226],"anti-infectives":[34,227],"into":[35],"clinic.":[37],"Besides":[38],"bacterial":[39,55,143],"killing,":[40],"host":[41,116],"viability":[43],"barrier":[45,126,192],"function":[46,193],"appear":[47],"as":[48],"relevant":[49],"but":[50],"seldomly":[51],"measured":[52],"readouts.":[53],"Moreover,":[54],"virulence":[56],"factors":[57],"signaling":[59],"molecules":[60,109,180],"are":[61],"typically":[62],"not":[63,187],"addressed":[64],"in":[65,202,205,215],"current":[66],"models.":[69],"Here,":[70],"we":[71],"describe":[72],"a":[73,213],"reproducible":[74],"protocol":[75],"cultivating":[77],"barrier-forming":[78],"bronchial":[80],"epithelial":[81,125,158,191],"monolayers":[83],"on":[84],"Transwell":[85],"inserts":[86],"infecting":[88],"them":[89],"with":[90,173],"microclusters":[91],"pre-grown":[93],"mature":[94],"Pseudomonas":[95],"aeruginosa":[96],"PAO1":[97],"biofilms":[98],"under":[99],"air\u2013liquid":[101],"interface":[102],"conditions.":[103],"Bacterial":[104],"growth":[105,144],"quorum":[107,178],"sensing":[108,179],"were":[110,181],"determined":[111],"upon":[112],"tobramycin":[113,136],"treatment.":[114],"The":[115],"response":[118],"was":[119,145,171,194],"simultaneously":[120],"assessed":[121],"through":[122],"viability,":[124],"function,":[127],"cytokine":[129],"release.":[130],"By":[131],"repeated":[132],"deposition":[133],"aerosolized":[135],"after":[137],"1,":[138],"24,":[139],"48":[141],"h,":[142],"controlled":[146],"(reduction":[147],"from":[148],"10":[149,153],"4":[151],"log":[152],"CFU/mL),":[154],"which":[155],"leads":[156],"survival":[160],"up":[162],"72":[164],"h.":[165],"E-cadherin\u2019s":[166],"cell\u2013cell":[167],"adhesion":[168],"protein":[169],"expression":[170],"preserved":[172],"consecutive":[175],"treatment,":[176],"reduced.":[182],"However,":[183],"bacteria":[185],"could":[186],"be":[188],"eradicated":[189],"impaired,":[195],"similar":[196],"currently":[199],"observed":[200],"situation":[201],"clinic":[204],"lack":[206],"more":[208],"efficient":[209],"anti-infective":[210],"therapies.":[211],"Such":[212],"human-based":[214],"vitro":[216],"approach":[217],"has":[218],"potential":[220],"preclinical":[223],"development":[224],"nanoscale":[229],"delivery":[230],"systems":[231],"oral":[233],"inhalation.":[234]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2021-12-31T00:00:00"}
